Augnition Labs was launched in 2020 with the mission of developing AI-powered digital assessment and monitoring solutions for early detection of cognitive decline. As the world’s population continues to age, the number of people living with dementia is expected to rise to more than 153 million by 2050.
Alzheimer's disease is the most common type of dementia. It is a progressive neurological illness, beginning with memory loss and leading to compromised thinking, language and decision making.
Memory Loss comes first.
As the search continues for successful therapies that treat or prevent Alzheimer’s disease, one thing is certain – sensitive detection of the disease’s earliest symptoms is key to effective intervention.
Augnition Labs is working to build products that address this area of need.
Read more about the science on our website.
Company Details
- Employees
- 5
- Founded
- -
- Address
- Irvine, Ca 92617, Us
- Industry
- Biotechnology
- Website
- http://www.augnitionlabs.com
- Keywords
- brain, CNS, biomarkers, clinical trials, biotechnology, healthcare, medicine, pharmaceuticals, cognitive testing, digital cognitive assessment, Alzheimer's disease, dementia, hippocampus.
- HQ
- Irvine, CA
Augnition Labs Questions
Augnition Labs's website is http://www.augnitionlabs.com
Augnition Labs's LinkedIn profile is https://www.linkedin.com/company/augnitionlabs
Augnition Labs has
5 employees.
View email and phone details for 5
employees at Augnition Labs.
Augnition Labs's industry is
Biotechnology
Augnition Labs's top competitors are
Blue Wave Therapeutics,
Iar80 Fly Again,
Prevision Medicine,
Basel Investor Forum,
Echonous,
Bxs Bv,
Stratosphere Networks, Llc,
Enthorin Therapeutics,
Hi-D Imaging,
Augnition Labs.
Augnition Labs's categories are Biotechnology
Augnition Labs's founding year is 2020
